Company intelligence / Profile preview

Avicella Capital

Delaware, United Statesavicellacapital.com ↗

Ownership: Private
Development stage: Other

Overview

Avicella Capital is a healthcare-focused venture capital fund investing globally in therapeutics, devices, diagnostics, and health tech companies with established proof-of-concept. The firm aims to back innovations that improve patient outcomes and revolutionize healthcare delivery. Recent investments include supporting Convergence Medical’s VO1 arthroscopic surgical robot through Series A funding.

Therapeutic areas: Other
Modalities: Small moleculeAntibodyDeviceAI-based health tech solutionsDiagnostics technology
Industry: Investors

Partnerships

Convergence Medical (for the VO1 surgical robot commercialisation/funding round)

Beyond the preview

Go deeper on Avicella Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avicella Capital.

Explore the full profile